Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors
- PMID: 37506345
- PMCID: PMC10579047
- DOI: 10.1182/blood.2023020441
Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors
Abstract
Human 12-lipoxygenase (12-LOX) is a key enzyme involved in platelet activation, and the regulation of its activity has been targeted for the treatment of heparin-induced thrombocytopenia. Despite the clinical importance of 12-LOX, the exact mechanisms by which it affects platelet activation are not fully understood, and the lack of structural information has limited drug discovery efforts. In this study, we used single-particle cryo-electron microscopy to determine high-resolution structures (1.7-2.8 Å) of human 12-LOX. Our results showed that 12-LOX can exist in multiple oligomeric states, from monomer to hexamer, which may affect its catalytic activity and membrane association. We also identified different conformations within the 12-LOX dimer, which likely represent different time points in its catalytic cycle. Furthermore, we identified small molecules bound to 12-LOX. The active site of the 12-LOX tetramer was occupied by an endogenous 12-LOX inhibitor, a long-chain acyl coenzyme A. In addition, we found that the 12-LOX hexamer can simultaneously bind to arachidonic acid and ML355, a selective 12-LOX inhibitor that has passed a phase 1 clinical trial for the treatment of heparin-induced thrombocytopenia and received a fast-track designation by the Food and Drug Administration. Overall, our findings provide novel insights into the assembly of 12-LOX oligomers, their catalytic mechanism, and small molecule binding, paving the way for further drug development targeting the 12-LOX enzyme.
© 2023 by The American Society of Hematology.
Conflict of interest statement
Conflict-of-interest disclosure: M.H. is an equity holder and serves on the scientific advisory board for Veralox Therapeutics and Cereno Scientific. M.H. and T.R.H. are coinventors of the patented compound ML355. The remaining authors declare no competing financial interests.
Figures






Comment in
-
Pass the 12-LOX!Blood. 2023 Oct 5;142(14):1180-1181. doi: 10.1182/blood.2023021939. Blood. 2023. PMID: 37796520 Free PMC article. No abstract available.
Similar articles
-
Thirty years with three-dimensional structures of lipoxygenases.Arch Biochem Biophys. 2024 Feb;752:109874. doi: 10.1016/j.abb.2023.109874. Epub 2023 Dec 23. Arch Biochem Biophys. 2024. PMID: 38145834 Review.
-
Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells.Mol Cancer Ther. 2006 May;5(5):1371-82. doi: 10.1158/1535-7163.MCT-06-0021. Mol Cancer Ther. 2006. PMID: 16731771
-
Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase.Bioorg Med Chem. 2021 Sep 15;46:116347. doi: 10.1016/j.bmc.2021.116347. Epub 2021 Aug 4. Bioorg Med Chem. 2021. PMID: 34507163
-
In Vitro Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2.Biochemistry. 2021 Jun 8;60(22):1741-1754. doi: 10.1021/acs.biochem.0c00931. Epub 2021 May 24. Biochemistry. 2021. PMID: 34029049 Free PMC article.
-
Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk.Biochem Pharmacol. 2022 Nov;205:115252. doi: 10.1016/j.bcp.2022.115252. Epub 2022 Sep 18. Biochem Pharmacol. 2022. PMID: 36130648 Review.
Cited by
-
Different Structures-Similar Effect: Do Substituted 5-(4-Methoxyphenyl)-1H-indoles and 5-(4-Methoxyphenyl)-1H-imidazoles Represent a Common Pharmacophore for Substrate Selective Inhibition of Linoleate Oxygenase Activity of ALOX15?Molecules. 2023 Jul 14;28(14):5418. doi: 10.3390/molecules28145418. Molecules. 2023. PMID: 37513289 Free PMC article.
-
Antiplatelet strategies: past, present, and future.J Thromb Haemost. 2023 Dec;21(12):3317-3328. doi: 10.1016/j.jtha.2023.09.013. J Thromb Haemost. 2023. PMID: 38000851 Free PMC article. Review.
-
High-resolution cryo-EM using a common LaB6 120-keV electron microscope equipped with a sub-200-keV direct electron detector.Sci Adv. 2025 Jan 3;11(1):eadr0438. doi: 10.1126/sciadv.adr0438. Epub 2025 Jan 3. Sci Adv. 2025. PMID: 39752481 Free PMC article.
-
Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes.Int J Mol Sci. 2024 Feb 13;25(4):2241. doi: 10.3390/ijms25042241. Int J Mol Sci. 2024. PMID: 38396917 Free PMC article. Review.
-
Pass the 12-LOX!Blood. 2023 Oct 5;142(14):1180-1181. doi: 10.1182/blood.2023021939. Blood. 2023. PMID: 37796520 Free PMC article. No abstract available.
References
-
- Willoughby S, Holmes A, Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs. 2002;1(4):273–288. - PubMed
-
- Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73–82. - PubMed